Search clinical trials for: Perennial Allergic Rhinitis pediatric

Total 18023 results

Alcon Research

Completed

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays

Rhinitis, Allergic, Perennial and Seasonal

Argentina, Russian Federation, Korea, Republic of, Australia
Johann Wolfgang Goethe University Hospital

Completed

Local IgE in Subjects With Allergic or Non-allergic Rhinitis (LISA)

Perennial Rhinitis

Germany
Eun Jung Kim
DongGuk University

Unknown

The Efficacy and Safety of Cettum for Perennial Allergic Rhinitis

Rhinitis, Allergic
Alcon Research

Completed

Safety Study of Olopatadine Nasal Spray

Perennial Allergic Rhinitis

United States
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
GlaxoSmithKline

Completed

Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber

Rhinitis, Allergic, Perennial

Germany
GlaxoSmithKline

Completed

Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
GlaxoSmithKline
Adelphi Real World

Completed

A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Rhinitis, Allergic, Perennial
GlaxoSmithKline

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Perennial

China
GlaxoSmithKline

Completed

Pharmacokinetic Study of Levocetirizine Oral Solution

Rhinitis, Allergic, Perennial and Seasonal

Japan
GlaxoSmithKline

Completed

A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis

Rhinitis, Allergic, Perennial and Seasonal

Canada
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
Entellus Medical, Inc.

Completed

Sinus Balloon Dilation in Pediatric Patients

Sinusitis

United States
GlaxoSmithKline

Completed

A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis

Rhinitis, Allergic, Perennial

Thailand
National Institute of Allergy and Infectious Diseases...
Inner-City Asthma Consortium

Completed

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

Asthma | Rhinitis, Allergic, Perennial

United States
Kyung Hee University Hospital at Gangdong
Pusan National University Hospital; DongGuk University; Kyung Hee University... and other collaborators

Unknown

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Korea, Republic of
ALK-Abelló A/S

Completed

Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis
GlaxoSmithKline

Completed

Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics

Rhinitis

Japan
Nasaleze International Ltd
Göteborg University

Completed

Cellulose Powder Against Grass Pollen Allergic Rhinitis (CPARGPDBPC)

Allergic Rhinitis

Sweden, Ukraine
GlaxoSmithKline

Completed

A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
GlaxoSmithKline

Completed

Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis

Japan
GlaxoSmithKline

Completed

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Rhinitis, Allergic, Perennial and Seasonal

Austria
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Rhinitis, Allergic, Perennial

Korea, Republic of
GlaxoSmithKline

Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

Estonia, United States, Canada, Germany, Slovakia, Russian Federation, Hungary
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
AstraZeneca

Completed

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis (SISRIP)

Seasonal Rhinitis | Perennial Rhinitis

Mexico
AstraZeneca

Completed

Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States, Canada
AstraZeneca

Completed

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

Rhinitis, Allergic, Perennial

United States
AstraZeneca

Completed

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

Rhinitis, Allergic, Perennial

United States
AstraZeneca

Completed

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Seasonal Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

Perennial Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Rhinitis, Allergic, Perennial

United States
Mariella Enoc
Bial Aristegui Italia srl; OPBG Contract and Research Organization

Unknown

Specific Immunotherapy for Allergic Child

Allergic Rhinitis | Allergic Asthma | Grass Allergy

Italy
GlaxoSmithKline

Completed

Long Term Safety Of GW685698X Via Nasal Biopsy

Rhinitis, Allergic, Perennial

Netherlands, Belgium
GlaxoSmithKline

Completed

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Rhinitis, Allergic, Perennial

United States, Canada
GlaxoSmithKline

Completed

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

Rhinitis, Allergic, Perennial and Seasonal

Denmark
GlaxoSmithKline

Completed

A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults

Rhinitis, Allergic, Perennial

United States, Canada
Peking Union Medical College Hospital

Unknown

Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

Rhinitis, Allergic, Perennial

China
Azidus Brasil
EMS S/A

Completed

Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

Perennial Allergic Rhinitis

Brazil
Norwegian University of Science and Technology
St. Olavs Hospital; Tine

Completed

Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic

Asthma | Rhinitis, Allergic, Perennial | Dermatitis, Atopic

Norway
Merck Sharp & Dohme LLC

Completed

A Study in Subjects With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan

3

Subscribe